260 related articles for article (PubMed ID: 24060698)
1. One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats.
Khafagy el-S; Kamei N; Nielsen EJ; Nishio R; Takeda-Morishita M
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):736-43. PubMed ID: 24060698
[TBL] [Abstract][Full Text] [Related]
2. Effect of cell-penetrating peptides on the nasal absorption of insulin.
Khafagy el-S; Morishita M; Isowa K; Imai J; Takayama K
J Control Release; 2009 Jan; 133(2):103-8. PubMed ID: 18930084
[TBL] [Abstract][Full Text] [Related]
3. Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins.
Khafagy el-S; Morishita M; Kamei N; Eda Y; Ikeno Y; Takayama K
Int J Pharm; 2009 Oct; 381(1):49-55. PubMed ID: 19646515
[TBL] [Abstract][Full Text] [Related]
4. Use of a non-covalent cell-penetrating peptide strategy to enhance the nasal delivery of interferon beta and its PEGylated form.
Iwase Y; Kamei N; Khafagy el-S; Miyamoto M; Takeda-Morishita M
Int J Pharm; 2016 Aug; 510(1):304-10. PubMed ID: 27343364
[TBL] [Abstract][Full Text] [Related]
5. Exploration of the Key Factors for Optimizing the in Vivo Oral Delivery of Insulin by Using a Noncovalent Strategy with Cell-Penetrating Peptides.
Kamei N; Shigei C; Hasegawa R; Takeda-Morishita M
Biol Pharm Bull; 2018; 41(2):239-246. PubMed ID: 29386483
[TBL] [Abstract][Full Text] [Related]
6. In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin.
Nielsen EJ; Yoshida S; Kamei N; Iwamae R; Khafagy el-S; Olsen J; Rahbek UL; Pedersen BL; Takayama K; Takeda-Morishita M
J Control Release; 2014 Sep; 189():19-24. PubMed ID: 24973720
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive insulin delivery: the great potential of cell-penetrating peptides.
Kamei N; Nielsen EJ; Khafagy el-S; Takeda-Morishita M
Ther Deliv; 2013 Mar; 4(3):315-26. PubMed ID: 23442079
[TBL] [Abstract][Full Text] [Related]
8. Structural requirements of penetratin absorption enhancement efficiency for insulin delivery.
Khafagy el-S; Morishita M; Ida N; Nishio R; Isowa K; Takayama K
J Control Release; 2010 May; 143(3):302-10. PubMed ID: 20096319
[TBL] [Abstract][Full Text] [Related]
9. Visualization and Quantitative Assessment of the Brain Distribution of Insulin through Nose-to-Brain Delivery Based on the Cell-Penetrating Peptide Noncovalent Strategy.
Kamei N; Shingaki T; Kanayama Y; Tanaka M; Zochi R; Hasegawa K; Watanabe Y; Takeda-Morishita M
Mol Pharm; 2016 Mar; 13(3):1004-11. PubMed ID: 26795701
[TBL] [Abstract][Full Text] [Related]
10. Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane.
Khafagy el-S; Iwamae R; Kamei N; Takeda-Morishita M
AAPS J; 2015 Nov; 17(6):1427-37. PubMed ID: 26216471
[TBL] [Abstract][Full Text] [Related]
11. [Nose-to-Brain Delivery of Peptide Drugs Enhanced by Coadministration of Cell-penetrating Peptides: Therapeutic Potential for Dementia].
Kamei N
Yakugaku Zasshi; 2017; 137(10):1247-1253. PubMed ID: 28966266
[TBL] [Abstract][Full Text] [Related]
12. The role of intermolecular interactions with penetratin and its analogue on the enhancement of absorption of nasal therapeutic peptides.
Khafagy el-S; Morishita M; Takayama K
Int J Pharm; 2010 Mar; 388(1-2):209-12. PubMed ID: 20060451
[TBL] [Abstract][Full Text] [Related]
13. Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides.
Kamei N; Takeda-Morishita M
J Control Release; 2015 Jan; 197():105-10. PubMed ID: 25445695
[TBL] [Abstract][Full Text] [Related]
14. Molecular imaging analysis of intestinal insulin absorption boosted by cell-penetrating peptides by using positron emission tomography.
Kamei N; Morishita M; Kanayama Y; Hasegawa K; Nishimura M; Hayashinaka E; Wada Y; Watanabe Y; Takayama K
J Control Release; 2010 Aug; 146(1):16-22. PubMed ID: 20457194
[TBL] [Abstract][Full Text] [Related]
15. Dependence of Intestinal Absorption Profile of Insulin on Carrier Morphology Composed of β-Cyclodextrin-Grafted Chitosan.
Daimon Y; Kamei N; Kawakami K; Takeda-Morishita M; Izawa H; Takechi-Haraya Y; Saito H; Sakai H; Abe M; Ariga K
Mol Pharm; 2016 Dec; 13(12):4034-4042. PubMed ID: 27749081
[TBL] [Abstract][Full Text] [Related]
16. Penetratin derivative-based nanocomplexes for enhanced intestinal insulin delivery.
Zhu X; Shan W; Zhang P; Jin Y; Guan S; Fan T; Yang Y; Zhou Z; Huang Y
Mol Pharm; 2014 Jan; 11(1):317-28. PubMed ID: 24255985
[TBL] [Abstract][Full Text] [Related]
17. Revealing the importance of carrier-cargo association in delivery of insulin and lipidated insulin.
Diedrichsen RG; Harloff-Helleberg S; Werner U; Besenius M; Leberer E; Kristensen M; Nielsen HM
J Control Release; 2021 Oct; 338():8-21. PubMed ID: 34298056
[TBL] [Abstract][Full Text] [Related]
18. Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium.
Kamei N; Aoyama Y; Khafagy el-S; Henmi M; Takeda-Morishita M
Eur J Pharm Biopharm; 2015 Aug; 94():42-51. PubMed ID: 25960330
[TBL] [Abstract][Full Text] [Related]
19. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
[TBL] [Abstract][Full Text] [Related]
20. Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats.
Jintapattanakit A; Peungvicha P; Sailasuta A; Kissel T; Junyaprasert VB
J Pharm Pharmacol; 2010 May; 62(5):583-91. PubMed ID: 20609059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]